UNH · 10-Q · 2026Q3 · Full report

Liquidity and Cash Position

UNITEDHEALTH GROUP INC · 2026-11-03 · Importance 58 · Surprise 56

Operating cash flow for the nine months ended September 30, 2026 was $25.087 billion, up $6.498 billion year over year, driven by higher earnings, government-payment timing, working-capital dynamics, and Inflation Reduction Act pharmacy-rebate changes. At September 30, 2026, cash, cash equivalents, and marketable securities totaled $78.3 billion, including $25.8 billion in cash and cash equivalents, of which $1.2 billion was available for general corporate use. The portfolio also included $50.3 billion of debt securities and $2.2 billion of marketable equity securities, alongside $11.5 billion of loan receivables. The debt-securities portfolio had a 4.3-year weighted-average duration and a Double-A weighted-average credit rating.

Key facts

• Cash flows from operations were $25.1 billion for the nine months ended September 30, 2026. source
• As of September 30, 2026, UnitedHealth Group had $78.3 billion in cash, cash equivalents and specified securities: approximately $25.8 billion in cash and cash equivalents, $50.3 billion in debt securities and $2.2 billion in marketable equity securities; $1.2 billion of cash and cash equivalents was available for general corporate use. source
• UnitedHealth Group had $11.5 billion of loan receivables as of September 30, 2026. source
• UnitedHealth Group’s available-for-sale debt and equity investment purchases net of sales totaled $4.486 billion in the nine months ended September 30, 2026. source